CDKN2A/B homozygous deletion sensitizes IDH-mutant glioma to CDK4/6 inhibition.
Nasser AM, Melamed L, Wetzel E, Chang CC, Nagashima H, Kitagawa Y, Muzyka L, Wakimoto H, Cahill DP, Miller JJ.
Nasser AM, et al. Among authors: chang cc.
Clin Cancer Res. 2024 May 8. doi: 10.1158/1078-0432.CCR-24-0562. Online ahead of print.
Clin Cancer Res. 2024.
PMID: 38718141